Jørgen Ulrik Vejlsgaard

Management, Salaniva ApS

Toldbodgade 36B, 3. mf5 active roles

Jørgen Ulrik Vejlsgaard holds 5 active roles in Danish companies registered in CVR, including Management at Salaniva ApS since 2024 and Board of Directors at Reapplix A/S since 2024. Jørgen Ulrik Vejlsgaard is registered as legal owner of Salaniva ApS (100% share band). 11 earlier roles have ended, the most recent in 2025.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

Career timeline

2024 – now
Board of Directors, Reapplix A/S
2024 – now
Legal Owner, North-East Health Care Holding ApS
2024 – now
Management, Salaniva ApS
2019 – now
Board of Directors, SNIPR Holdings ApS
2019 – 2025
Board of Directors, SNIPR Biome ApS
2019 – 2023
Board of Directors, North-East Health Care Investment ApS
2018 – 2022
Stakeholder, Boliginteressentskabet Charlotte August
2015
Board of Directors, A&A GROUP HOLDING A/S
2013 – now
Founder, CASUN ApS
2012 – 2023
Board of Directors, 7TM A/S
2012 – 2023
Founder, 7TM HOLDING ApS
2007 – 2011
Board of Directors, LINA MEDICAL ApS
2007
Liquidator, COPENHAGEN BIOTECH ASSETS ApS
2000 – 2023
Founder, BAKKE & CO. ApS
1999 – 2000
Founder, KOMMA ApS
1998 – 2007
Founder, NOAPAB HOLDINGS A/S

Personal details

Address

Toldbodgade 36B, 3. mf

Companies & roles

Active roles

5 positions

Company	Role	Period	Ownership	Status
CASUN ApS CVR 35396098	OtherFounder	Since 2013	20–24.99%	Active
Reapplix A/S CVR 31261570	BoardBoard of Directors	Since 2024	—	Active
North-East Health Care Holding ApS CVR 36934484	OwnerLegal Owner	Since 2024	10–14.99%	Active
SNIPR Holdings ApS CVR 38847120	BoardBoard of Directors	Since 2019	—	Active
Salaniva ApS CVR 44555506	ManagementManagement	Since 2024	100%	Active

Historical roles

11 positions

Company	Role	Period	Ownership	Status
SNIPR Biome ApS CVR 38871277	BoardBoard of Directors	2019 – 2025	—	Active
NOAPAB HOLDINGS A/S CVR 21392073	OtherFounder	1998 – 2007	—	Dissolved
KOMMA ApS CVR 21572446	OtherFounder	1999 – 2000	—	Dissolved
7TM A/S CVR 25108523	BoardBoard of Directors	2012 – 2023	—	Dissolved
BAKKE & CO. ApS CVR 25777514	OtherFounder	2000 – 2023	—	Dissolved
A&A GROUP HOLDING A/S CVR 82928219	BoardBoard of Directors	2015 – 2015	—	Dissolved
COPENHAGEN BIOTECH ASSETS ApS CVR 26557852	OtherLiquidator	2007 – 2007	—	Dissolved
7TM HOLDING ApS CVR 34491682	OtherFounder	2012 – 2023	—	Dissolved
North-East Health Care Investment ApS CVR 36935545	BoardBoard of Directors	2019 – 2023	—	Dissolved
Boliginteressentskabet Charlotte August CVR 39787873	OtherStakeholder	2018 – 2022	—	Active
LINA MEDICAL ApS CVR 10054974	BoardBoard of Directors	2007 – 2011	—	Active

Network

Company network

Active roles

Jørgen Ulrik Vejlsgaard

North-East Health Care Holding ApS

Past companies

SNIPR Biome ApS NOAPAB HOLDINGS A/S KOMMA ApS 7TM A/S BAKKE & CO. ApS A&A GROUP HOLDING A/S COPENHAGEN BIOTECH ASSETS ApS 7TM HOLDING ApS North-East Health Care Investment ApS Boliginteressentskabet Charlotte August LINA MEDICAL ApS

Co-directors & shared companies

Person	Role	Shared companies	Profile
LG Lauxera Growth I S.L.P	Legal Owner	1company	View profile
JS Jan Struve	Legal Owner	1company	View profile
BJ Bo Jesper Hansen	Legal Owner	1company	View profile
KE Klaus Eldrup-Jørgensen	Chairman	1company	View profile
SL Samuel Levy	Board of Directors	1company	View profile

Is this you? About the data on this page

This profile is compiled automatically from CVR / Virk, the official business register in Denmark. Riskpilot is operated by Risika A/S, which is the data controller for this page. We don't add private information — only the roles and details the register itself publishes.

Because this is public register data, it can't be erased — corrections to the underlying record are made with the register, and we pick them up once they're published. You do have the right to object to how your details are shown here, and we can de-index this profile so it no longer appears in search engines such as Google.

To make a request, email privacy@risika.com with a link to this page. We respond within 30 days. Read more in our privacy policy.